Sarfo F S, Phillips R O, Ampadu E, Sarpong F, Adentwe E, Wansbrough-Jones M
Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Clin Vaccine Immunol. 2009 Jan;16(1):61-5. doi: 10.1128/CVI.00235-08. Epub 2008 Nov 12.
We have studied the evolution of the gamma interferon (IFN-gamma) and interleukin 10 (IL-10) responses after Mycobacterium ulcerans sonicate stimulation of whole blood from patients with early M. ulcerans lesions during treatment with rifampin and streptomycin for 8 weeks. Among the 26 patients, secretion of IFN-gamma increased during treatment, with a significant increase at 4 weeks and a further increase after 8 weeks overall. The increase was more rapid in patients with large or ulcerative lesions, becoming significant by 4 weeks. For small lesions, there was only a minor increase, which did not reach significance. There was no significant change in the median IL-10 response during antibiotic therapy, and there was no inverse correlation between IFN-gamma and IL-10 responses. These results demonstrate that an IFN-gamma secretory response to M. ulcerans developed, independently of IL-10 secretion, in patients whose M. ulcerans disease healed during antibiotic therapy.
我们研究了在利福平与链霉素联合治疗8周期间,用溃疡分枝杆菌超声裂解物刺激早期溃疡分枝杆菌病患者全血后,γ干扰素(IFN-γ)和白细胞介素10(IL-10)反应的演变情况。在26例患者中,治疗期间IFN-γ的分泌增加,总体上在4周时显著增加,8周后进一步增加。大的或溃疡性病变患者的增加更为迅速,在4周时变得显著。对于小病变患者,仅略有增加,未达到显著水平。抗生素治疗期间IL-10反应的中位数无显著变化,且IFN-γ与IL-10反应之间无负相关。这些结果表明,在抗生素治疗期间溃疡分枝杆菌病愈合的患者中,出现了对溃疡分枝杆菌的IFN-γ分泌反应,且该反应独立于IL-10分泌。